Deepika Pakianathan, Director at Karyopharm Therapeutics Inc. (KPTI), sold 1,446,338 shares at $0.95 ($1.4M) on 2024-05-31, disclosed to the SEC on 2024-06-04.
Open-market sale of $1.4M KPTI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.95 | 1,976 | $2K | 0.1% |
| 2 | $0.95 | 202,418 | $192K | 13.8% |
| 3 | $0.95 | 202,418 | $192K | 13.8% |
| 4 | $1.00 | 3,488 | $3K | 0.3% |
| 5 | $1.00 | 357,256 | $357K | 25.7% |
| 6 | $0.95 | 3,298 |
| $3K |
| 0.2% |
| 7 | $0.95 | 337,742 | $321K | 23.0% |
| 8 | $0.95 | 337,742 | $321K | 23.0% |
| Total | $0.96 avg | 1,446,338 | $1.4M | 100% |
| Filing → |
| CALA | SELL | 2023-01-31 | $47K | — | Filing → |
| KPTI | SELL | 2022-06-10 | $6.8M | — | Filing → |
| KPTI | BUY | 2015-01-14 | $1.5M | — | Filing → |